NutriBand Inc. (NTRB) is the 85th largest of 126 Generic Drugs companies by market capitalisation, at 70.38 Mn, behind Pelthos Therapeutics Inc. at 84.59 Mn. The table below compares all 126 on 8 financial metrics.
| # | Ticker | Company | match | industry_code | industry_group | industry_group_code | Market Capitalization | P/E | P/S | Enterprise Value |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | TEVA | Teva Pharmaceutical Industries Ltd | primary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 42.84 Bn | 61.56 | 2.47 | 39.19 Bn |
| 2 | VTRS | Viatris Inc | primary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 19.13 Bn | -46.58 | 1.30 | 18.24 Bn |
| 3 | RDY | Dr Reddys Laboratories Ltd | primary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 9.91 Bn | 785.46 | 2.70 | 9.74 Bn |
| 4 | AMRX | Amneal Pharmaceuticals, Inc. | primary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 5.51 Bn | 25.57 | 1.77 | 5.38 Bn |
| 5 | BHC | Bausch Health Companies Inc. | primary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 2.30 Bn | -2.11 | 0.21 | 0.46 Bn |
| 6 | ALVO | Alvotech | primary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 1.50 Bn | -5.39 | 4.38 | 1.36 Bn |
| 7 | ANIP | Ani Pharmaceuticals Inc | primary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 1.49 Bn | 13.80 | 1.52 | 1.13 Bn |
| 8 | AMPH | Amphastar Pharmaceuticals, Inc. | primary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 1.00 Bn | 12.03 | 1.38 | 0.71 Bn |
| 9 | FENC | Fennec Pharmaceuticals Inc. | primary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 0.40 Bn | -90.65 | 7.48 | 0.36 Bn |
| 10 | RDHL | RedHill Biopharma Ltd. | primary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 0.18 Bn | -434.89 | 37.17 | 0.18 Bn |
| 11 | NTRB | NutriBand Inc. | primary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 0.07 Bn | -10.11 | 43.51 | 0.07 Bn |
| 12 | BGM | BGM Group Ltd. | primary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | — | — | 0.02 Bn |
| 13 | ETST | Earth Science Tech, Inc. | primary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | 6.76 | 0.72 | 0.02 Bn |
| 14 | NXPL | NextPlat Corp | primary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -2.54 | 0.52 | 0.01 Bn |
| 15 | COSM | Cosmos Health Inc. | primary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -0.76 | 0.21 | 0.01 Bn |
| 16 | SCNX | Scienture Holdings, Inc. | primary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -0.89 | 34.94 | 0.01 Bn |
| 17 | AEON | AEON Biopharma, Inc. | primary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -0.24 | — | 0.01 Bn |
| 18 | PMHS | Polomar Health Services, Inc. | primary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -0.59 | 1.78 | 0.01 Bn |
| 19 | SXTP | 60 Degrees Pharmaceuticals, Inc. | primary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.38 | 2.25 | 0.00 Bn |
| 20 | SBFM | Sunshine Biopharma Inc. | primary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.27 | 0.04 | -0.01 Bn |
| 21 | QNRX | Quoin Pharmaceuticals, Ltd. | primary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | — | — | 0.00 Bn |
| 22 | PRFX | PRF Technologies Ltd. | primary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.18 | 53.74 | -0.01 Bn |
| 23 | GRMLW | Greenland Mines Ltd | primary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.02 | — | -0.01 Bn |
| 24 | TMO | Thermo Fisher Scientific Inc. | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 225.48 Bn | 32.03 | 4.87 | 221.41 Bn |
| 25 | ABT | Abbott Laboratories | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 183.04 Bn | 33.74 | 3.93 | 177.44 Bn |
| 26 | PFE | Pfizer Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 158.57 Bn | 36.30 | 2.49 | 146.88 Bn |
| 27 | IQV | Iqvia Holdings Inc. | secondary | H-11 | Pharma Services | HG-03 | 42.77 Bn | 32.40 | 2.52 | 40.69 Bn |
| 28 | BIIB | Biogen Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 31.15 Bn | 37.32 | 3.11 | 29.86 Bn |
| 29 | ZTS | Zoetis Inc. | secondary | H-05 | Pharmaceuticals and Biotechnology | HG-01 | 30.63 Bn | 9.36 | 3.22 | 28.95 Bn |
| 30 | LH | Labcorp Holdings Inc. | secondary | H-17 | Healthcare Providers | HG-04 | 26.30 Bn | 26.21 | 1.83 | 26.16 Bn |
| 31 | WST | West Pharmaceutical Services Inc | secondary | H-07 | Medical Devices and Diagnostics | HG-02 | 23.94 Bn | 43.58 | 7.20 | 23.51 Bn |
| 32 | GH | Guardant Health, Inc. | secondary | H-17 | Healthcare Providers | HG-04 | 21.64 Bn | -47.72 | 18.29 | 20.59 Bn |
| 33 | IFF | International Flavors & Fragrances Inc | secondary | M-02 | Chemicals | MG-01 | 21.50 Bn | 73.64 | 2.15 | 20.93 Bn |
| 34 | STE | STERIS plc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 21.02 Bn | 26.01 | 3.48 | 20.54 Bn |
| 35 | MEDP | Medpace Holdings, Inc. | secondary | H-11 | Pharma Services | HG-03 | 16.50 Bn | 33.58 | 5.93 | 16.00 Bn |
| 36 | LDOS | Leidos Holdings, Inc. | secondary | I-02 | Aerospace and Defense | IG-01 | 16.21 Bn | 11.62 | 0.92 | 15.46 Bn |
| 37 | CRL | Charles River Laboratories International, Inc. | secondary | H-11 | Pharma Services | HG-03 | 13.37 Bn | -56.26 | 3.34 | 13.18 Bn |
| 38 | BAX | Baxter International Inc | secondary | H-07 | Medical Devices and Diagnostics | HG-02 | 12.66 Bn | 550.61 | 1.14 | 10.51 Bn |
| 39 | ICLR | Icon Plc | secondary | H-11 | Pharma Services | HG-03 | 12.49 Bn | 16.05 | 1.51 | 11.56 Bn |
| 40 | CORT | Corcept Therapeutics Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 12.16 Bn | 224.28 | 14.63 | 11.85 Bn |
| 41 | DVA | Davita Inc. | secondary | H-14 | Healthcare Providers | HG-04 | 11.90 Bn | 10.22 | 0.85 | 11.21 Bn |
| 42 | TEM | Tempus AI, Inc. | secondary | H-17 | Healthcare Providers | HG-04 | 11.04 Bn | -44.44 | 7.71 | 10.23 Bn |
| 43 | PODD | Insulet Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 9.53 Bn | 25.39 | 3.12 | 9.00 Bn |
| 44 | IONS | Ionis Pharmaceuticals Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 9.24 Bn | -43.52 | 10.57 | 7.18 Bn |
| 45 | TWST | Twist Bioscience Corp | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 7.86 Bn | -57.50 | 18.21 | 7.70 Bn |
| 46 | ALKS | Alkermes plc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 7.58 Bn | 114.56 | 4.54 | 6.92 Bn |
| 47 | GIFLF | Grifols SA | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 7.54 Bn | 29.70 | 0.46 | 9.09 Bn |
| 48 | CAI | Caris Life Sciences, Inc. | secondary | H-17 | Healthcare Providers | HG-04 | 6.82 Bn | 64.87 | 6.89 | 6.03 Bn |
| 49 | LNTH | Lantheus Holdings, Inc. | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 6.56 Bn | 23.84 | 4.22 | 5.97 Bn |
| 50 | HIMS | Hims & Hers Health, Inc. | secondary | H-16 | Healthcare Providers | HG-04 | 6.41 Bn | -45.14 | 2.49 | 5.57 Bn |
| 51 | BLCO | Bausch & Lomb Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 6.33 Bn | -38.86 | 1.19 | 5.96 Bn |
| 52 | LQDA | Liquidia Corp | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 6.14 Bn | 44.31 | 13.62 | 5.86 Bn |
| 53 | LGND | Ligand Pharmaceuticals Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 5.78 Bn | 29.31 | 19.90 | 4.42 Bn |
| 54 | ADPT | Adaptive Biotechnologies Corp | secondary | H-17 | Healthcare Providers | HG-04 | 3.92 Bn | -97.29 | 12.71 | 3.57 Bn |
| 55 | TLPPF | Telix Pharmaceuticals Ltd | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 3.89 Bn | -521.64 | 4.64 | 3.59 Bn |
| 56 | OGN | Organon & Co. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 3.59 Bn | 17.20 | 0.59 | 2.46 Bn |
| 57 | ABCL | AbCellera Biologics Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 3.37 Bn | -20.49 | 50.98 | 3.37 Bn |
| 58 | NEO | Neogenomics Inc | secondary | H-17 | Healthcare Providers | HG-04 | 2.30 Bn | -44.29 | 3.00 | 2.15 Bn |
| 59 | ADMA | Adma Biologics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.15 Bn | 12.91 | 4.19 | 2.01 Bn |
| 60 | NVAX | Novavax Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.63 Bn | -6.57 | 3.93 | 0.91 Bn |
| 61 | SCNI | Scinai Immunotherapeutics Ltd. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.63 Bn | -194.01 | 943.71 | 1.62 Bn |
| 62 | FTRE | Fortrea Holdings Inc. | secondary | H-11 | Pharma Services | HG-03 | 1.58 Bn | -18.59 | 0.59 | 1.42 Bn |
| 63 | HROW | Harrow, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.41 Bn | -42.04 | 5.10 | 1.32 Bn |
| 64 | IART | Integra Lifesciences Holdings Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 1.25 Bn | -172.77 | 0.76 | 0.98 Bn |
| 65 | MGTX | MeiraGTx Holdings plc | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 1.21 Bn | 7.34 | 3.02 | 1.07 Bn |
| 66 | MRVI | Maravai Lifesciences Holdings, Inc. | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 1.03 Bn | -7.55 | 4.92 | 0.96 Bn |
| 67 | LXRX | Lexicon Pharmaceuticals, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.94 Bn | -15.00 | 22.74 | 0.75 Bn |
| 68 | QDEL | QuidelOrtho Corp | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 0.87 Bn | — | — | 0.74 Bn |
| 69 | AVR | Anteris Technologies Global Corp. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.83 Bn | -9.97 | 369.48 | 0.83 Bn |
| 70 | EVO | Evotec SE | secondary | H-11 | Pharma Services | HG-03 | 0.64 Bn | — | — | 0.22 Bn |
| 71 | AQST | Aquestive Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.64 Bn | -8.19 | 11.84 | 0.54 Bn |
| 72 | OABI | OmniAb, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.52 Bn | -11.67 | 13.43 | 0.46 Bn |
| 73 | RGNX | REGENXBIO Inc. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.46 Bn | -2.60 | 2.44 | 0.36 Bn |
| 74 | DNA | Ginkgo Bioworks Holdings, Inc. | secondary | H-11 | Pharma Services | HG-03 | 0.42 Bn | -1.45 | 3.78 | 0.34 Bn |
| 75 | CLPT | ClearPoint Neuro, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.42 Bn | -14.40 | 9.92 | 0.39 Bn |
| 76 | EYPT | EyePoint, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.37 Bn | -1.21 | 134.36 | 0.19 Bn |
| 77 | WDH | Waterdrop Inc. | secondary | F-16 | Insurance | FG-04 | 0.37 Bn | 4.77 | 0.51 | 0.19 Bn |
| 78 | STRO | Sutro Biopharma, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.31 Bn | -2.69 | 3.39 | 0.14 Bn |
| 79 | EMBC | Embecta Corp. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.30 Bn | 3.45 | 0.30 | 0.08 Bn |
| 80 | IMRX | Immuneering Corp | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.30 Bn | -5.02 | — | 0.30 Bn |
| 81 | EBS | Emergent BioSolutions Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.29 Bn | -1.67 | 0.38 | 0.15 Bn |
| 82 | BDSX | Biodesix Inc | secondary | H-17 | Healthcare Providers | HG-04 | 0.28 Bn | -9.83 | 2.74 | 0.25 Bn |
| 83 | MGNX | Macrogenics Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.26 Bn | -16.20 | 1.56 | 0.15 Bn |
| 84 | OSUR | Orasure Technologies Inc | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 0.24 Bn | — | 2,445.63 | 0.05 Bn |
| 85 | UTMD | Utah Medical Products Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.22 Bn | 22.43 | 6.13 | 0.13 Bn |
| 86 | AGPU | Axe Compute Inc. | secondary | T-44 | Cloud Computing | TG-07 | 0.22 Bn | -8.68 | — | 0.19 Bn |
| 87 | DERM | Journey Medical Corp | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.20 Bn | -55.91 | 3.00 | 0.18 Bn |
| 88 | SLGL | Sol-Gel Technologies Ltd. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.19 Bn | -18.55 | 108.38 | 0.15 Bn |
| 89 | XGN | Exagen Inc. | secondary | H-17 | Healthcare Providers | HG-04 | 0.18 Bn | -9.32 | 2.48 | 0.15 Bn |
| 90 | IMDX | Insight Molecular Diagnostics Inc. | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 0.15 Bn | -2.77 | 90.00 | 0.13 Bn |
| 91 | KRMD | KORU Medical Systems, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.15 Bn | -61.85 | 3.22 | 0.14 Bn |
| 92 | APYX | Apyx Medical Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.13 Bn | -15.44 | 2.28 | 0.11 Bn |
| 93 | MXCT | Maxcyte, Inc. | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 0.13 Bn | -3.70 | 4.25 | 0.13 Bn |
| 94 | CDXS | Codexis, Inc. | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 0.13 Bn | -4.27 | 1.69 | 0.08 Bn |
| 95 | NRXP | NRX Pharmaceuticals, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.13 Bn | -5.99 | 36.76 | 0.10 Bn |
| 96 | BNR | Burning Rock Biotech Ltd | secondary | H-17 | Healthcare Providers | HG-04 | 0.11 Bn | -12.74 | 1.40 | 0.04 Bn |
| 97 | PTHS | Pelthos Therapeutics Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.08 Bn | -0.76 | 1.57 | 0.06 Bn |
| 98 | CSBR | Champions Oncology, Inc. | secondary | H-11 | Pharma Services | HG-03 | 0.07 Bn | -58.86 | 1.16 | 0.07 Bn |
| 99 | XBIT | XBiotech Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.07 Bn | -1.60 | — | 0.07 Bn |
| 100 | HYFT | MindWalk Holdings Corp. | secondary | H-11 | Pharma Services | HG-03 | 0.06 Bn | -5.79 | 5.31 | 0.05 Bn |
| 101 | CELU | Celularity Inc | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.04 Bn | -0.42 | 1.44 | 0.03 Bn |
| 102 | SCLX | Scilex Holding Co | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.04 Bn | -0.08 | 1.13 | -0.08 Bn |
| 103 | BHST | Bioharvest Sciences Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | -3.16 | 0.95 | 0.02 Bn |
| 104 | NSYS | Nortech Systems Inc | secondary | I-04 | Machinery | IG-02 | 0.03 Bn | 12.07 | 0.37 | 0.03 Bn |
| 105 | LASE | Laser Photonics Corp | secondary | I-04 | Machinery | IG-02 | 0.03 Bn | -0.87 | 5.12 | 0.03 Bn |
| 106 | YDESW | YD Bio Ltd | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | — | — | 0.03 Bn |
| 107 | ABVC | Abvc Biopharma, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | -3.57 | — | 0.03 Bn |
| 108 | AYTU | Aytu Biopharma, Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -0.73 | 0.40 | 0.00 Bn |
| 109 | LGVN | Longeveron Inc. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -0.88 | 17.51 | 0.01 Bn |
| 110 | HIND | Vyome Holdings, Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -1.21 | 111.46 | 0.01 Bn |
| 111 | PBSV | Pharma-Bio Serv, Inc. | secondary | I-26 | Business Services | IG-06 | 0.01 Bn | 238.12 | 1.36 | 0.00 Bn |
| 112 | NAII | Natural Alternatives International Inc | secondary | H-12 | Pharma Services | HG-03 | 0.01 Bn | -0.84 | 0.09 | 0.00 Bn |
| 113 | PLUR | Pluri Inc. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | 0.00 | 8.92 | 0.00 Bn |
| 114 | GELS | Gelteq Ltd | secondary | H-12 | Pharma Services | HG-03 | 0.01 Bn | — | — | 0.01 Bn |
| 115 | MGRX | Mangoceuticals, Inc. | secondary | H-16 | Healthcare Providers | HG-04 | 0.01 Bn | -0.44 | 22.73 | 0.01 Bn |
| 116 | DQWS | DSwiss Inc | secondary | S-11 | Household and Personal Products | SG-05 | 0.01 Bn | -27.32 | 4.18 | 0.01 Bn |
| 117 | AIDX | 20/20 Biolabs, Inc. | secondary | H-17 | Healthcare Providers | HG-04 | 0.01 Bn | -0.95 | 2.83 | 0.00 Bn |
| 118 | CLGN | CollPlant Biotechnologies Ltd | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.63 | 10.73 | 0.00 Bn |
| 119 | STLNW | Starling Oncology, Inc. | secondary | H-14 | Healthcare Providers | HG-04 | 0.00 Bn | -0.14 | 0.01 | -0.04 Bn |
| 120 | BFRGW | BullFrog AI Holdings, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.31 | 5.53 | -0.01 Bn |
| 121 | VIVS | VivoSim Labs, INC. | secondary | H-11 | Pharma Services | HG-03 | 0.00 Bn | -0.13 | 12.96 | 0.00 Bn |
| 122 | SKVI | Skinvisible, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -1.05 | 54.04 | 0.00 Bn |
| 123 | CPMV | Mosaic ImmunoEngineering Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.64 | — | 0.00 Bn |
| 124 | NOTVQ | Inotiv, Inc. | secondary | H-11 | Pharma Services | HG-03 | 0.00 Bn | 0.00 | 0.00 | -0.01 Bn |
| 125 | FCHS | First Choice Healthcare Solutions, Inc. | secondary | H-14 | Healthcare Providers | HG-04 | 0.00 Bn | -0.05 | — | 0.00 Bn |
| 126 | NXGLW | Nexgel, Inc. | secondary | H-12 | Pharma Services | HG-03 | 0.00 Bn | -0.02 | 0.01 | 0.00 Bn |